Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
14.15
-0.21 (-1.46%)
At close: Aug 1, 2025, 4:00 PM
13.87
-0.28 (-1.98%)
After-hours: Aug 1, 2025, 7:56 PM EDT
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $516.44 million as of August 1, 2025. Its market cap has decreased by -46.01% in one year.
Market Cap
516.44M
Enterprise Value
238.90M
1-Year Change
-46.01%
Ranking
Category
Stock Price
14.15
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has decreased from $601.40M to $516.44M, a decrease of -14.13%. That is a compound annual growth rate of -12.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 516.44M | -20.41% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |